SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: I. Luttichuys who wrote (362)2/13/1997 11:31:00 PM
From: James Perry   of 1762
 
Bennett: Give Gene Medicine (GMED) a quick look when you get a minute. Their revenue increased greatly last year, tho they still lose money. The have a relationship with BMG. My best read is that they are trying to administer gene materials to try to affect other genes to cause a cure. Point is, I bought it not too long ago and it has doubled, so I am beginning to get suspicious that there might be something here. My research looked interesting but I confess I had no hint it was ready to move so rapidly. Maybe it all is resultant from the revenue increase.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News